Lock the standard
Intended use, SOP, ICH-GCP clause set, TMF plan, or CSA procedure. The model is not allowed to invent a different bar.
Clinical quality and compliance
CliniGene supports quality, clinical, and validation teams with practical work: audit maps, Veeva managed services, CSA rationale, vendor files, SOPs, eTMF review, and mock inspections. AI drafts the first pass. A specialist reviews before anything is official.
GCP audit readiness is not a slide deck. It is whether an auditor can follow a subject, a visit, a deviation, or a consent from the protocol to a filed artifact, and whether your quality system can explain what is missing. CliniGene uses AI to do the first pass of that mapping at scale. A GCP specialist then writes the official findings.
Agree which trial(s), which sites if any, which systems (eTMF, CTMS, EDC, safety, IRT), and whether this is a sponsor audit, CRO oversight, for-cause, or inspection prep. Write what “ready” means in one paragraph so the AI is not given a wandering brief.
Protocol family, TMF plan and index, SOP list with effective dates, monitoring plan, CAPA log, and exports you can legally share. We work in a restricted workspace. We do not use your files to train public models.
AI extracts enforceable requirements from ICH-GCP and your SOPs (not guidance fluff). The specialist edits the library — this is the checklist the rest of the work is scored against.
Inventory extract vs. requirement library. Each row is present / weak / missing / not applicable, with a pointer. Weak means the artifact exists but is unsigned, wrong version, or does not cover the date range.
Every AI-suggested finding is accepted, merged, rewritten, or dismissed. Dismissals are kept so you can show an inspector the machine was not the decision-maker.
Patient safety, data integrity, and inspection visibility. High-visibility items (consent, IP, SAE reporting, investigator oversight) are called out even when the TMF “completeness %” looks fine.
Clause-to-evidence matrix, finding register with reviewer name, CAPA drafts, and a briefing: the ten questions an auditor will ask first and where the answer lives.
When you upload the new artifact, AI re-runs only those rows. Closed means new evidence, not a status flip.
A Vault that is “live” is not finished. Releases arrive, roles drift, tickets pile up, and the SOP no longer matches the screens. CliniGene operates Veeva as a managed service: we keep intended use current, classify work, draft change and release assessments, and support administration under your change-control SOP. Your Vault owner still approves what goes to production.
Which applications, who the system owner is, how access is granted, and what “managed” covers this quarter (admin only, releases, changes, or all three).
Intended use, configuration workbook (or a first harvest if you never had one), last validation summary, and the ticket/change SOP we will follow.
Release calendar, change intake, access requests, and a weekly or biweekly review. AI drafts; named people decide.
Users, roles, overlays, and documented configuration work under your access rules. We do not improvise in production.
Impact draft → specialist review → delta-validation or documented rationale that nothing GxP-critical moved → your quality approval.
Enhancements go through impact, SOP check, test ideas, and your change control. Drift that appeared without a change is a finding, not a feature.
Workbook, release assessments, ticket themes, and residual risk stay current. That file is what CSV/CSA and inspection-readiness will ask for.
What we operated, what still belongs to you, SOP deltas, and whether the managed scope should grow or shrink.
Computer system validation (CSV) and computer software assurance (CSA) are how you prove a GxP system is fit for intended use. CSA asks you to think: which functions can harm a subject or the data, and what assurance is already available from the vendor? CliniGene uses AI to draft intended use, risk scenarios, and test ideas from your manuals and SOPs. Your CSA owner decides the official mix of scripted tests, unscripted assurance, and vendor evidence.
One system owner, one validation lead, one quality approver. CSA fails when “everyone” owns it.
Workshop + AI draft + edit. Include what the system must not be used for (e.g. not the legal source of a submission number).
From manuals and admin screens. Mark GxP-critical vs. administrative.
Walk high-impact functions. AI comes with a draft FMEA-style list; the room scores and cuts.
Vendor pack, automated tests, unscripted sessions, scripted IQ/OQ/PQ — each with a why. This is the CSA record.
We draft protocols and the evidence index. Testers execute under your SOP. Deviations are written with AI-assisted language; classification is human.
Summary report ties each critical function to evidence. Residual risk is listed, not hidden.
A checklist and a place to drop the next release notes so the next review is a diff, not a rewrite.
Email hello@clini-gene.com with a sentence about the audit, Vault, or inspection. We will suggest the right starting point.
Vendor qualification is a file you can hand an inspector: questionnaire, quality agreement, audit or desktop review, CAPAs, certificates, and the last periodic review. CliniGene uses AI to inventory what arrived, map answers to your SOP and Part 11/Annex 11 expectations, and flag contradictions. The qualification decision is always a person.
What they do on this trial or in this QMS, including known subcontractors.
Workshop using your SOP. AI may suggest; you lock the tier so the rest of the file is consistent.
Questionnaire, QA draft, DPA, validation/assurance summary, certs, org/quality contacts.
AI gap list + control map. QA sends one consolidated query list, not a week of scattered emails.
Desktop or on-site/remote audit. We prepare; your qualified auditor (or ours if engaged as such) issues findings.
Redline roles, deviations, CAPA, audit rights, data return, subcontracting notice. Legal and QA both see it.
Approve, conditional (with dated conditions), or reject. Conditions become tracked CAPAs in your system.
KPI pack and a calendar. On review, AI diffs new evidence; you decide whether the tier or approval still holds.
Inspectors read your SOP and then watch the process. If those two stories differ, you have a finding. CliniGene develops controlled documents from interviews and the real system, not from a generic template dump. AI produces the structured first draft and a cross-SOP conflict list. Your process owner and QA revise; document control makes it effective.
Which SOP family or which validation pack. Name the owner and QA reviewer before drafting.
Live system or last inspection path. Record the ugly exceptions; they belong in the SOP or they will become deviations.
AI inventory + process map. Owner confirms “this is how we work” or we stop and fix the process first.
SOP/WI/form or VP/RA/protocol/report in your template.
Comment log. AI can cluster comments; resolution is human. We keep the log for the approval packet.
Sibling SOPs, validation names, form fields vs. procedure steps.
What changed and who must be trained before effective.
You publish. We do not click Effective in your QMS unless that is explicitly in the engagement and your SOP allows it.
Email hello@clini-gene.com with a sentence about the audit, Vault, or inspection. We will suggest the right starting point.
eTMF quality is not a green dashboard. It is whether the artifact that should exist for this milestone exists, is the right version, is identifiable to the study/site, and would survive an inspector reading it. CliniGene uses AI to pre-score inventory and documents. TMF specialists perform official QC and decide what is a miss vs. an allowed lag.
Which TMF plan version, which milestone, 100% vs. sample QC, and which artifact types are always 100% (usually consent and investigator).
Vault or other eTMF. Agree what “collected” means in your report (placeholder ≠ collected).
Expected vs. actual. Output is a list, not only a percentage.
AI pre-score then specialist QC per your checklist. Fail reasons are coded so themes are real.
Intake, site, or CRO process changes — not only “please refile.”
% expected collected, % QC passed, placeholder aging, inspection-first list.
Each miss has a name and a date. We do not leave a 400-row spreadsheet with no owner.
On re-upload, re-score those rows. Report the delta.
Inspection readiness is whether people and documents tell the same story under time pressure. CliniGene assembles the narrative and the war-room index with AI, then runs mock front-room / back-room drills. Findings are written by reviewers who have sat in those rooms. We do not invent a regulatory opinion or predict a 483.
Authority, scope (study, site, sponsor system, vendor), dates, and known history. Write what “ready” means for this event.
AI draft + specialist edit. This becomes the briefing the leadership team shares — one story.
Every likely question → artifact path. Gaps become the punch list (and often feed eTMF review and GCP mapping).
Who sits where, who scribes, how a document is requested, how an audit trail is pulled, who says “we will get that.”
Front room / back room. We interrupt, ask for the document, and compare the spoken answer to the file. Contradictions are findings.
For PAI or computer-system scope: rooms, access, backup, clock sync, account provisioning. Gaps on the same register.
Readiness score by theme (consent, oversight, IP, safety, data integrity, systems, prior commitments). Briefing book the team can actually use.
Owned tasks. We can re-score the index after close. We do not claim you will have zero observations.
Intended use, SOP, ICH-GCP clause set, TMF plan, or CSA procedure. The model is not allowed to invent a different bar.
AI produces matrices, scripts, QC flags, and first drafts. A named specialist accepts, edits, or rejects each item.
Findings, dismissals, and re-checks are kept so you can show what was machine-assisted and what a person signed.
Built for organizations that already own GxP decisions and want the document and review cycle shortened — not the quality unit replaced.
Email hello@clini-gene.com or send the form. Mention the study, Vault, vendor, or inspection date if you have one.
Email hello@clini-gene.com if you prefer not to use the form.